Searchable abstracts of presentations at key conferences in endocrinology

ea0005s17 | Dominant Endocrine Cancer Syndromes | BES2003

VHL and HIF, a basis for VHL pathogenesis

Pugh C

The interplay between the von Hippel Lindau (VHL) protein and hypoxia-inducible factor (HIF) will be reviewed and the extent to which this explains the pathogenesis of VHL disease will be discussed.HIF is a master regulator of the transcriptional response to diminished tissue oxygenation, controlling such processes as angiogenesis, erythropoietin production, cellular metabolism and influencing cell proliferation / survival decisions. HIF itself is a heterodimer, dominantly...

ea0005p83 | Diabetes, Metabolism and Cardiovascular | BES2003

Testosterone is a dilator of resistance arteries in men with congestive heart failure

Malkin C , Pugh P , Jones R , Jones T , Channer K

BackgroundHeart failure is a syndrome of vaso-constriction and hormone abnormalities. There is an excess of catabolic and vasoconstrictor hormones and a relative deficiency of anabolic hormones. Vaso-dilating drugs improve symptoms in heart failure and inhibition of some catabolic / vasoconstrictor hormones improves prognosis. We aimed to study the direct vascular effects of testosterone resistance arteries from men with heart failure.Methods6 resistance arteries w...

ea0005p100 | Diabetes, Metabolism and Cardiovascular | BES2003

Treatment of coronary disease and effects on endogenous testosterone levels

Malkin C , Pugh P , Jones T , Channer K

Background. Males with coronary disease have lower levels of endogenous testosterone than unaffected males. It is not known if low testosterone is a cause, effect or an epi-phenomenon of ischaemic heart disease.We hypothesised that androgen deficient men treated surgically with complete resolution of their symptoms would have a higher subsequent testosterone than men with persistent angina.Methods. Subjects were recruited after angiography. All subjects were biochemically ...

ea0009oc9 | Oral Communication 1: Diabetes and metabolism | BES2005

Testosterone improves funtional capacity and symptoms in men with chronic heart failure: a double blind placebo controlled trial

Malkin C , Pugh P , Jones R , van Beek E , West J , Channer K , Jones T

Chronic heart failure (CHF) is associated with maladaptive and prolonged neurohormonal and pro-inflammatory cytokine activation causing a metabolic shift favouring catabolism, vasodilator incapacity, and loss of skeletal muscle bulk and function. In men, androgens are important determinants of anabolic function and physical strength and also possess anti-inflammatory and vasodilatory properties. We conducted a randomised, double blind, placebo controlled trial of testosterone ...

ea0007p22 | Cytokines and growth factors | BES2004

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men

Malkin C , Pugh P , Jones R , Kapoor D , Channer K , Jones T

Testosterone has immune-modulating properties and current in-vitro evidence suggests that testosterone may suppress the expression of the pro-inflammatory cytokines Tumour Necrosis Factor (TNF alpha), interleukin (IL)-1 beta and IL-6 and potentiate the expression of the anti-inflammatory cytokine IL-10. We report a randomised single-blind placebo-controlled crossover study of testosterone replacement (Sustanon 100) versus placebo in 27 men (age 62+-9years) with symptomatic and...